Skip to main content Skip to section navigation Skip to footer
PolarityTE, Inc. PolarityTE, Inc. PolarityTE, Inc. PolarityTE, Inc.
  • Company
    • About PolarityTE
    • Management
    • Board of Directors
  • R & D
    • Our Technology
    • Our Focus on Complex Wounds
    • Scientific Presentations and Publications
  • Patients & Families
    • Our Mission
    • Expanded Access Program
    • Research
    • Clinical Trials
  • Investors & News
    • News & Events
    • Contacts
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Clinical Trials & Pipeline
    • Clinical Trials
    • Our Pipeline
  • Join Our Team
  • Contact
PolarityTE PolarityTE
  • Company
    • About PolarityTE
    • Management
    • Board of Directors
  • R & D
    • Our Technology
    • Our Focus on Complex Wounds
    • Scientific Presentations and Publications
  • Patients & Families
    • Our Mission
    • Expanded Access Program
    • Research
    • Clinical Trials
  • Investors & News
    • News & Events
    • Contacts
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Clinical Trials & Pipeline
    • Clinical Trials
    • Our Pipeline
  • Join Our Team
  • Contact

Presentations

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
  • Contacts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Executive Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Policy
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations

Investor Presentation September 2022

2021 Annual Report to Stockholders

rss_feed RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

Contact Info


PolarityTE Headquarters:
1960 South 4250 West
Salt Lake City, UT 84104


Corporate Main: 800-560-3983
Investor Relations: 385-831-5284
Public Relations: 800-656-6194
Clinical Research: 800-653-8031

More Contact Info  

Quick Links

  • Company
  • R&D
  • Patients & Families
  • Clinical Trials & Pipeline
  • Investors & News
  • Join Our Team
©2023 PolarityTE, Inc. All Rights Reserved. Patents Pending.
Privacy Policy | PO Terms | Distributors | Purchase Agreement Terms | Disclaimer